3220 related articles for article (PubMed ID: 3415851)
1. Karyometric findings and prognosis of stage I cutaneous malignant melanomas.
Lindholm C; Hofer PA; Jonsson H
Acta Oncol; 1988; 27(3):227-33. PubMed ID: 3415851
[TBL] [Abstract][Full Text] [Related]
2. Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis.
Lindholm C; Hofer PA; Jonsson H; Tribukait B
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):147-51. PubMed ID: 2575819
[TBL] [Abstract][Full Text] [Related]
3. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.
Talve LA; Collan YU; Ekfors TO
J Cutan Pathol; 1996 Aug; 23(4):335-43. PubMed ID: 8864921
[TBL] [Abstract][Full Text] [Related]
4. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
[TBL] [Abstract][Full Text] [Related]
5. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
6. Single cell DNA cytophotometry in clinical stage I malignant melanoma. Relationship to prognosis.
Lindholm C; Hofer PA; Jonsson H
Acta Oncol; 1990; 29(2):147-50. PubMed ID: 2334568
[TBL] [Abstract][Full Text] [Related]
7. Morphometric analysis in prognostic evaluation of stage I thick cutaneous melanomas.
Mauri MF; Boi S; Micciolo R; Cristofolini M; Dalla Palma P
Anal Quant Cytol Histol; 1997 Aug; 19(4):311-5. PubMed ID: 9267564
[TBL] [Abstract][Full Text] [Related]
8. DNA level, tumor thickness, and stereological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact.
Sørensen FB; Kristensen IB; Grymer F; Jakobsen A
Am J Dermatopathol; 1991 Feb; 13(1):11-9. PubMed ID: 2003643
[TBL] [Abstract][Full Text] [Related]
9. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
10. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
[TBL] [Abstract][Full Text] [Related]
11. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis.
Li LX; Crotty KA; Palmer AA; Kril JJ; Stankovic R; Scolyer RA; McCarthy SW
Anal Quant Cytol Histol; 2002 Aug; 24(4):234-43. PubMed ID: 12199325
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of clinicopathologic variables and DNA ploidy in stage I cutaneous malignant melanoma.
Tralongo V; Daniele E; Leonardi V; Rodolico V
Oncol Rep; 1998; 5(5):1095-8. PubMed ID: 9683815
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in primary cutaneous malignant melanoma.
Sondergaard K; Schou G
Am J Dermatopathol; 1985; 7 Suppl():1-4. PubMed ID: 3940069
[TBL] [Abstract][Full Text] [Related]
15. Karyometry of primary and metastatic malignant melanoma. A correlation with cell proliferation.
Piérard-Franchimont C; Piérard GE
Am J Dermatopathol; 1994 Jun; 16(3):247-52. PubMed ID: 7943630
[TBL] [Abstract][Full Text] [Related]
16. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of prognostic characteristics of stage I cutaneous malignant melanoma.
Tan GJ; Baak JP
Anal Quant Cytol; 1984 Sep; 6(3):147-54. PubMed ID: 6508033
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.
Talve L; Kainu J; Collan Y; Ekfors T
Pathol Res Pract; 1996 Aug; 192(8):825-33. PubMed ID: 8897518
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-12 expression is increased in cutaneous melanoma and associated with tumor aggressiveness.
Zhang Z; Zhu S; Yang Y; Ma X; Guo S
Tumour Biol; 2015 Nov; 36(11):8593-600. PubMed ID: 26040769
[TBL] [Abstract][Full Text] [Related]
20. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
